$ENVA

ENVA Rallies As Enova Tops Q2 And Targets Grasshopper Bank Synergies

Enova International Inc. (NYSE: ENVA) shares rose about 9% after Q2 results and guidance-related optimism. The company reported adjusted EPS of $4.31 vs $3.96 consensus and revenue of $928.9M vs $764M prior year, with operating cash flow of $544M and $531.4M free cash flow. Analysts reportedly raised price targets to $257-$280, citing the Grasshopper Bank acquisition and improving credit metrics.

Original reporting
Published Jul 26, 2026, 3:34 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 27, 2026, 12:08 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
ENVA Rallies As Enova Tops Q2 And Targets Grasshopper Bank Synergies — source image
Decision brief

The 30-second read

$ENVABullishMed
01

Why it matters

For traders, the actionable elements are the cited Q2 beat (EPS and revenue), the acquisition synergy narrative, and the stated technical levels (support near ~$230, consolidation risk toward ~$222, resistance near ~$250-$255).

02

Market read

ENVA is presented as experiencing a fresh earnings-led momentum leg with specific beats and near-term technical levels that traders can use for risk management.

03

What to watch

Grasshopper Bank synergy benefits are asserted without timeline, integration costs, or regulatory/credit assumptions; the move may be more sentiment-driven than fundamentals.

Relevance 7/10Novelty 6/10Timing: during the Jul 26, 2026 session after the Q2-driven move and fresh analyst target updates

Background

The piece frames Enova’s stock strength as earnings momentum plus an acquisition (Grasshopper Bank) that should add deposits and product breadth.

Company-level read

Ticker impact

$ENVABullishMedium confidence
Context

Enova shares rally ~9% as the article cites Q2 EPS and revenue beats plus analyst target hikes and Grasshopper Bank synergy claims.

Expected impact

Near-term upside bias while price holds the cited ~$230 support; a break below could trigger consolidation toward the ~$222 area mentioned.

Evidence & confidence

The text provides specific Q2 beat figures, cash flow/liquidity metrics, and a named acquisition synergy driver, but it does not verify whether these are newly released today versus already known.

Market effects

Supports a positive read-through for specialty finance and credit-sensitive lenders if the acquisition and credit metrics are sustained.

No specific regional market linkage beyond US-listed trading.

No explicit global macro or cross-border linkage in the text.

Counterpoint

The article emphasizes leverage and credit sensitivity but does not quantify downside risk; if charge-offs or funding costs re-accelerate, the momentum could fade quickly.

Key entities

  • Enova International Inc.

    NYSE-listed specialty finance platform discussed as the subject of the earnings and acquisition synergy narrative.

  • Grasshopper Bank

    Acquired entity referenced as a driver of deposit funding and product breadth for Enova.

Related articles

$OPFIMed

OppFi and Enova Bank Deals Put Lending Under Scrutiny

Attorneys general asked the Federal Reserve, OCC and FDIC to deny banking privileges tied to OppFi’s $130M acquisition of BNCCORP and BNC National Bank and Enova’s proposed acquisition of Grasshopper Bancorp and Grasshopper Bank. AGs allege bank partnerships bypass state loan-rate caps and cite high rates and charge-offs. OppFi and Enova project deposit and revenue synergies and EPS accretion.

$ENVAMedAI 8/10

Enova International Stock Jumps After Powerful Q2 Beat

Enova International Inc. (NYSE: ENVA) shares rose about 9% during the week after the company reported Q2 2026 results and raised guidance. Adjusted EPS was $4.31 versus $3.96 expected, with revenue up to $928.9M from $764M. Management cited record $5.5B loans, improving margins, and ongoing share repurchases.

$ENVAMed

ENVA Jumps As Enova Earnings Beat Fuels Bullish Targets

Enova International Inc. (NYSE: ENVA) shares rose about 9% after its Q2 2026 results. The company reported adjusted EPS of $4.31 versus $3.23 a year earlier and revenue of $928.9M versus $764M, alongside a consumer credit outlook. Analysts cited bullish targets of $257 to $280 and support near $230.

$ENVAMedAI 8/10

Enova International Signals Strong Growth and Rising EPS

Enova International (ENVA) reported Q2 results and said consolidated originations rose 27% YoY to nearly $2.3B and total revenue rose 22% to $929M. Adjusted EPS increased 33% YoY to $4.31. Credit metrics improved, with net charge-offs at 7.3%. Management raised Q3 and 2026 guidance and noted the pending Grasshopper Bank deal awaits regulatory approval.

$ENVAMedAI 8/10

Enova Reports Second Quarter 2026 Results

Enova International (NYSE: ENVA) reported Q2 2026 results. Total revenue rose 22% to $929 million. Diluted EPS was $4.00, up 40%, and adjusted EPS was $4.31, up 33%. Credit metrics stayed strong, with net charge-offs at a 7.3% ratio and net revenue margin at 61%. Enova also repurchased $19 million of stock and reported $929 million liquidity at June 30.